Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Abstracts

Abstracts

  • Wednesday, October 2, 2024
  • 8:00 AM - 8:10 AM ET
    334 - Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Model in Oliogmetastatic Castration-Sensitive Prostate Cancer, including in Patients from the STOMP and ORIOLE Phase II Rando
    Location: Room 207
    Presenter: Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 8:10 AM - 8:20 AM ET
    333 - A Digital Pathology Multimodal Artificial Intelligence Algorithm is Associated with Pro-Metastatic Genomic Pathways in Oligometastatic Prostate Cancer
    Location: Room 207
    Presenter: Yang Song, PhD – University of Maryland
  • 8:20 AM - 8:30 AM ET
    335 - A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African American and Non-African American Men with Prostate Cancer (VANDAAM STUDY)
    Location: Room 207
    Presenter: Kosj Yamoah, MD, PhD – H. Lee Moffitt Cancer Center and Research Institute
  • 8:30 AM - 8:40 AM ET
    336 - Examination of Decipher Prostate Genomic Classifier in Patients with De Novo Metastatic Disease from a Large Scale Real-World Clinical and Transcriptomic Data Linkage
    Location: Room 207
    Presenter: Shalini Moningi, MD – Brigham and Women's Hospital/Dana-Farber
  • 8:40 AM - 8:50 AM ET
    337 - The Interplay between Acute and Late Toxicity among Patients Receiving Prostate Radiotherapy: A Pooled Analysis of 7 Randomized Trials
    Location: Room 207
    Presenter: John Nikitas, MD – UCLA Radiation Oncology
  • 8:50 AM - 9:00 AM ET
    338 - Prostate Cancer Integrated Risk Evaluation (P-CARE): A Model to Stratify Risk of Any, Metastatic, and Fatal Prostate Cancer
    Location: Room 207
    Presenter: Anna Dornisch, MD – UC San Diego
  • 8:00 AM - 8:10 AM ET
    339 - FLASH Proton Radiotherapy on a Model of Radiation-Induced Myocardial Fibrosis
    Location: Room 143
    Presenter: Ioannis Verginadis, PhD, MS – University of Pennsylvania
  • 8:10 AM - 8:20 AM ET
    340 - Contribution of Cardiac Macrophages and Interferon Signaling to the Therapeutic Effects of Cardiac Radiation in Heart Failure
    Location: Room 143
    Presenter: Lauren Pedersen, PhD – Washington University School of Medicine
  • 8:20 AM - 8:30 AM ET
    341 - Targeting Angiotensin and Inflammation to Prevent Radiotherapy-Induced Bladder Toxicity
    Location: Room 143
    Presenter: Brian Marples, PhD, FASTRO – University of Rochester
  • 8:30 AM - 8:40 AM ET
    342 - Gut Microbiota and Radiation Induced Intestine Injury through Modulating Tissue Resident Macrophage Homeostasis
    Location: Room 143
    Presenter: Yue Zhao, MD, PhD – China
  • 8:40 AM - 8:50 AM ET
    343 - Targeting mettl3 to Reglate p53 Oscillatory Activation Promotes DNA Damage Repair in Intestinal Stem Cells after Radiation
    Location: Room 143
    Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
  • 8:50 AM - 9:00 AM ET
    344 - Effects of DKK3 on radiation-induced inflammatory and fibrosing skin damage
    Location: Room 143
    Presenter: Peter Huber, MD, PhD – German Cancer Research Center (DKFZ)
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 204
  • 8:05 AM - 8:10 AM ET
    1109 - A Novel Comprehensive Multi-Omic Biosignature to Assess Recurrence Risk and Adjuvant Therapy Benefit in Early-Stage Hormone-Positive Invasive Breast Cancer Patients
    Location: Room 204
    Presenter: Naamit Gerber, MD – NYU Langone Medical Center
  • 8:10 AM - 8:15 AM ET
    1110 - Toxicity after Proton Beam Therapy for New and Recurrent Breast Cancer
    Location: Room 204
    Presenter: Madeline Schumacher, BS – University of Cincinnati College of Medicine
  • 8:15 AM - 8:20 AM ET
    1111 - Pre-Operative Boost Results in Low Rates of Re-Excision and Reduced Time from Initial Diagnosis to Completion of Local-Regional Treatment in Breast Cancer Patients
    Location: Room 204
    Presenter: Molly Chakraborty, BSE – Rutgers New Jersey Medical School
  • 8:20 AM - 8:25 AM ET
    1112 - Clinical Characteristics of Breast Cancer Patients with Lung Changes Following Intensity Modulated Proton Therapy
    Location: Room 204
    Presenter: Matthew Case, MD – Emory University
  • 8:25 AM - 8:55 AM ET
    Questions and Answers
    Location: Room 204
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 204
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 144
  • 8:05 AM - 8:10 AM ET
    1119 - Normalization of Lactate Dehydrogenase (LDH) as a Potential Prognostic Factor for Relapsed/Refractory Aggressive B-Cell Lymphoma (R/R BCL) Patients Receiving CAR T Following Bridging Radiotherapy: Res
    Location: Room 144
    Presenter: Monica Chelius, MD – University of Pennsylvania
  • 8:10 AM - 8:15 AM ET
    1120 - Salvage Radiotherapy in LBCL After First Line Chemo-immunotherapy: Can We Avoid CAR-T Therapy?
    Location: Room 144
    Presenter: Jessica Brady, MD, MB, ChB – Guy's and St. Thomas' NHS Foundation Trust
  • 8:15 AM - 8:20 AM ET
    1121 - Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Location: Room 144
    Presenter: Justyn Nakashima, DO – Moffitt Cancer Center
  • 8:20 AM - 8:25 AM ET
    1122 - Radiation Therapy as a Bridging Strategy in CAR-T Cell Therapy and the Impact of Tumor Control Status at CAR-T Cell Infusion
    Location: Room 144
    Presenter: Takuya Shimizuguchi, MD – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
  • 8:25 AM - 8:30 AM ET
    1123 - Ultra-Hypofractionated Involved Site Radiation Therapy (ISRT) as Salvage or Bridging Therapy in Aggressive Non-Hodgkin Lymphomas
    Location: Room 144
    Presenter: Tanooha Veeramachaneni, BS – UT Southwestern Medical School
  • 8:30 AM - 8:35 AM ET
    1124 - Results of a Comprehensive Prospective Protocol of Radiotherapy Bridging and Consolidation for CAR T in Large B Cell Lymphoma (RESTART)
    Location: Room 144
    Presenter: George Mikhaeel, MD, MBBS – Guy's Cancer Center
  • 8:35 AM - 8:55 AM ET
    Questions & Answers
    Location: Room 144
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 144
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 147
  • 8:05 AM - 8:10 AM ET
    1113 - Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction
    Location: Room 147
    Presenter: Haohua Wang
  • 8:10 AM - 8:15 AM ET
    1114 - Incorporating Predicted Weekly Anatomies into IMPT Robust Optimization in Nasopharyngeal Cancers
    Location: Room 147
    Presenter: Mark Ka Heng Chan, PhD – University Nebraska Medical Center
  • 8:15 AM - 8:20 AM ET
    1115 - Plan-Specific Range Tolerance Method for CBCT Triggered Adaptive Plans in Intensity Modulated Proton Therapy: Pilot Study on Head and Neck
    Location: Room 147
    Presenter: Weiguang Yao, PhD – University of Maryland School of Medicine, Baltimore
  • 8:20 AM - 8:25 AM ET
    1116 - Assessing Dose Uncertainties in Cardiac SBRT due to Cardiorespiratory Motion: Photon vs. Proton Therapy Comparison
    Location: Room 147
    Presenter: Guangjun Li, PhD – West China Hospital of Sichuan University
  • 8:25 AM - 8:30 AM ET
    1117 - A New RBE Optimization Method with Iterative Jacobian-Based Linearization for Carbon Ion Radiation Therapy
    Location: Room 147
    Presenter: Chao Wang, PhD – University of Kansas Medical Center
  • 8:30 AM - 8:35 AM ET
    1118 - Split Field IMPT Optimization to Maximize OAR Dose Rate and Implications for the Minimal FLASH Effect
    Location: Room 147
    Presenter: Ke Sheng, PhD – University of California, San Francisco
  • 8:35 AM - 8:55 AM ET
    Questions and Answers
    Location: Room 147
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 147
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 145
  • 8:05 AM - 8:10 AM ET
    1125 - Assessing the Feasibility and Dosimetric Impact of a Non-Animal Stabilized Hyaluronic Acid (NASHA) Rectal Spacer in High-Dose-Rate Brachytherapy for Prostate Cancer
    Location: Room 145
    Presenter: Reema Patel, BS – University of Virginia School of Medicine
  • 8:10 AM - 8:15 AM ET
    1126 - CT Dosimetry in Radioembolization: Image Acquisition Considerations
    Location: Room 145
    Presenter: Alasdair Syme, PhD – Nova Scotia Health Authority
  • 8:15 AM - 8:20 AM ET
    1127 - Prediction of Radiotherapy Efficacy of Esophageal Cancer Using Radiomics Temporal Sequence Extracted from Weekly CBCT
    Location: Room 145
    Presenter: Hui Wu, MD, PhD – Henan Cancer Hospital
  • 8:20 AM - 8:25 AM ET
    1128 - Novel Introduction of In Vivo Dynamic Nuclear Polarized MRI for the Visual Verification of IMRT
    Location: Room 145
    Presenter: Takayuki Mori, MD – Gifu University School of Medicine
  • 8:25 AM - 8:30 AM ET
    1129 - A Multi-Center Study on the Clinical Deliverability of Fully Automated Planning for Stereotactic Body Radiation Therapy in Lung Cancer Using a Deep Learning Transfer Method
    Location: Room 145
    Presenter: Jinghui Pan, PhD, MS – Renmin Hospital of Wuhan University
  • 8:30 AM - 8:35 AM ET
    1130 - Development of a Predictive Model for Rectal Toxicity in Prostate Cancer
    Location: Room 145
    Presenter: Ibrahim Chamseddine, PhD – Massachusetts General Hospital, Harvard Medical School
  • 8:35 AM - 8:55 AM ET
    Questions & Answers
    Location: Room 145
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 145
  • 9:15 AM - 9:35 AM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Jan Seuntjens, PhD – Princess Margaret Cancer Centre, University Health Network, University of Toronto
  • 9:35 AM - 9:55 AM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Charu Aggarwal, MD – University of Pennsylvania
  • 9:55 AM - 10:15 AM ET
    Discussant
    Location: Ballroom A/B/C
    Discussant: Matthias Guckenberger, MD – University Zurich and University Hospital Zurich
  • 10:30 AM - 10:40 AM ET
    1131 - Macropathology and Multimodal Magnetic Resonance Image Based Deep Learning Model for Personalized Definition of Target Volume in Patients with Glioma
    Location: Room 151
    Presenter: Nie Shulun, MD, PhD – Shandong Cancer Hospital and Institute
  • 10:40 AM - 10:50 AM ET
    1133 - Defining the Occult Margin in Recurrent Glioblastoma Using Spectroscopic MRI: Implications for Radiation Therapy Volumes
    Location: Room 151
    Presenter: Eric Mellon, MD, PhD – University of Miami
  • 10:50 AM - 11:00 AM ET
    1134 - Histologic Classifier of Radiosensitivity to Spine SBRT
    Location: Room 151
    Presenter: Christopher Jackson, MD, MS – Memorial Sloan Kettering Cancer Center
  • 11:00 AM - 11:10 AM ET
    1135 - Analysis of Late Cognitive Outcomes after Whole Brain Radiotherapy and Radiosurgery for Brain Metastases in the North Central Cancer Treatment Group (NCCTG) N0574 and N107C Clinical Trials
    Location: Room 151
    Presenter: Alan Nichol, MD, FRCPC – BC Cancer - Vancouver Centre
  • 11:10 AM - 11:20 AM ET
    1136 - Clinical Endpoints Correlation with Molecular Features in the NRG Oncology/RTOG 9802 Low-Grade Glioma, Low-Risk Observation Arm
    Location: Room 151
    Presenter: Jessica Fleming, PhD – The Ohio State University
  • 11:20 AM - 11:30 AM ET
    2614 - Metabolic Profiling of Adult and Pediatric Glioma Tumor Samples Uncovers Intrinsic Metabolic Differences between Adult Glioblastomas and Pediatric High-Grade Histone H3 Mutant Gliomas
    Location: Room 151
    Presenter: Vladislav Sviderskiy, MD, PhD – Washington University School of Medicine in St. Louis
  • 10:30 AM - 10:35 AM ET
    Introduction
    Location: Room 143
  • 10:35 AM - 10:40 AM ET
    1137 - Impact of Aging on the Efficacy of Radiotherapy Combined with Immunotherapy and its Mechanism in a Mouse Model of Rectal Cancer
    Location: Room 143
    Presenter: Yan Wang, MD, PhD – Fudan University Shanghai Cancer Center
  • 10:40 AM - 10:45 AM ET
    1138 - Bcl-2 Inhibitor Combined with Radiotherapy and Anti-Tumor Immune Response through Inducing Immunogenic Cell Death
    Location: Room 143
    Presenter: Mengmeng Ma, MD
  • 10:45 AM - 10:50 AM ET
    1139 - Cross-Cancer Analysis Reveals Distinct Pattern of Immune Modulation during Curative Radiotherapy
    Location: Room 143
    Presenter: Badr Id Said, MD, MS – MD Anderson Cancer Center
  • 10:50 AM - 10:55 AM ET
    1140 - Perturbation of Gut Microbiota Modulated the Abscopal Effects of Immunoradiotherapy in Rectal Cancer.
    Location: Room 143
    Presenter: Zhuang Xue, MD
  • 10:55 AM - 11:00 AM ET
    1141 - TIGIT Inhibitor Combined with Local Radiotherapy and PD-1 Inhibitor in a Syngenic Breast Cancer Model
    Location: Room 143
    Presenter: In Ah Kim, MD, PhD – Seoul National University
  • 11:00 AM - 11:05 AM ET
    1142 - Macrophages Play Key Role in Protecting Salivary Glands from Radiation Induced Damage
    Location: Room 143
    Presenter: Randall Kimple, MD, PhD, MBA, FASTRO – Univ of Wisconsin
  • 11:05 AM - 11:25 AM ET
    Questions and Answers
    Location: Room 143
  • 11:25 AM - 11:30 AM ET
    Closing
    Location: Room 143
  • 10:30 AM - 10:40 AM ET
    351 - Multi-Institutional Comparison of Ablative 5-Fraction MR-Guided Online Adapted vs. 15/25-Fraction CT-Guided Offline Adapted Radiation Therapy for Locally Advanced Pancreas Cancer
    Location: Room 144
    Presenter: Michael Chuong, MD – Miami Cancer Institute
  • 10:40 AM - 10:50 AM ET
    352 - The Effect of Tumor Biological Effective Dose (BED) on Stereotactic Body Radiotherapy (SBRT) Outcomes for Locally Advanced Cholangiocarcinoma (CCA): An Analysis of the ABC-07 Randomized Trial
    Location: Room 144
    Presenter: Maria Hawkins, MD – University College London
  • 10:50 AM - 11:00 AM ET
    353 - Safety and Efficacy Results of a Phase II Clinical Trial Evaluating Moderately-Hypofractionated Chemoradiotherapy for Pancreatic Ductal Adenocarcinoma
    Location: Room 144
    Presenter: Kenneth Merrell, MD, MS – Mayo Clinic Alix School of Medicine
  • 11:00 AM - 11:10 AM ET
    Discussant
    Location: Room 144
    Discussant: Parag Parikh, MD, BSE – Henry Ford Hospital
  • 11:10 AM - 11:20 AM ET
    354 - NRG Oncology International Consensus Atlas on Target Volumes for Dose-Escalated Pancreatic Cancer Radiotherapy
    Location: Room 144
    Presenter: Nina Sanford, MD – UT Southwestern Medical Center
  • 11:20 AM - 11:30 AM ET
    355 - Survival Prediction with Albumin-Bilirubin (ALBI) Changes in Hepatocellular Carcinoma Patients Treated with External Beam Radiotherapy (EBRT)
    Location: Room 144
    Presenter: Smith Apisarnthanarax, MD – University of Washington
  • 11:30 AM - 11:40 AM ET
    Discussant
    Location: Room 144
    Discussant: Kimberly Johung, MD, PhD – Yale University School of Medicine
  • 10:30 AM - 10:40 AM ET
    345 - Commissioning, Quality Assurance, and First Canine Treatment with a Conformal Proton Flash Delivery System
    Location: Room 145
    Presenter: Eric Diffenderfer, PhD – University of Pennsylvania
  • 10:40 AM - 10:50 AM ET
    346 - Multi-Contrast MRI Acceleration with K-Space Progressive Learning and Image-Space Self-to-Peer Aggregation
    Location: Room 145
    Presenter: Lianli Liu, PhD – Stanford University
  • 10:50 AM - 11:00 AM ET
    347 - Longitudinal Trends in Myocardial Metabolism following Non-Invasive Cardiac Radioablation for Ventricular Tachycardia Using PET-CT
    Location: Room 145
    Presenter: Carmen Bergom, MD, PhD – Washington University School of Medicine
  • 11:00 AM - 11:10 AM ET
    348 - Scintillation Imaging Dosimetry for High-Temporal Resolution Error Detection During UHDR Proton Beam Delivery
    Location: Room 145
    Presenter: Megan Clark, BS – Dartmouth College
  • 11:10 AM - 11:20 AM ET
    349 - Predicting Radiation Pneumonitis with Robust 4DCT-Ventilation and 4DCT-Perfusion Imaging Using Prospective Lung Cancer Clinical Trial Data
    Location: Room 145
    Presenter: Taindra Neupane, PhD – Sidney Kimmel Cancer Center at Thomas Jefferson University
  • 11:20 AM - 11:30 AM ET
    350 - Artificial Intelligence-Assisted Quantitative CT Analysis of Airway Changes Following SABR for Central Lung Tumors
    Location: Room 145
    Presenter: Omar Bohoudi, PhD – Amsterdam UMC location VUMC
  • 12:30 PM - 12:35 PM ET
    Introduction
    Location: Room 151
  • 12:35 PM - 12:40 PM ET
    1149 - Immunological effectiveness of carbon ion radiotherapy in pancreatic cancer
    Location: Room 151
    Presenter: Brett Bell, MS – Albert Einstein College of Medicine
  • 12:40 PM - 12:45 PM ET
    1150 - Investigating the Roles of the Epithelial-Mesenchymal Transition Program in Small Cell Lung Cancer Tumorigenesis and Chemoradiation Response
    Location: Room 151
    Presenter: Triet Nguyen, BA – Johns Hopkins Medicine
  • 12:45 PM - 12:50 PM ET
    1151 - Oral Bifidobacterium Longum BL21 Supplements in the Prevention of Acute Radiation-induced Intestinal Injury: A Single-Arm, Phase 2 Trial
    Location: Room 151
    Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
  • 12:50 PM - 12:55 PM ET
    1152 - Radiotherapy-Induced Tumor Cell Senescence Reprograms Anti-Tumor Immunity in a p21 Dependent Manner
    Location: Room 151
    Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
  • 12:55 PM - 1:00 PM ET
    1153 - Molecular Mechanisms Underlying Liver Metastasis in Hypofractionated Radiotherapy-Resistant Colorectal Cancer
    Location: Room 151
    Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
  • 1:00 PM - 1:05 PM ET
    1154 - A Lymph Node Immune Score (LNIS) Identifies Prognostic Immune Phenotypes Shared across Head and Neck Cancers
    Location: Room 151
    Presenter: Michael Spiotto, MD, PhD – The University of Texas MD Anderson Cancer Center
  • 1:05 PM - 1:25 PM ET
    Questions and Answers
    Location: Room 151
  • 1:25 PM - 1:30 PM ET
    Closing
    Location: Room 151
  • 12:30 PM - 12:35 PM ET
    Introduction
    Location: Room 144
  • 12:35 PM - 12:40 PM ET
    1143 - Rethinking Breast Irradiation Using Volumetric Modulated Arc Therapy with the Integration of Static Angle Ports and Dynamic Collimator
    Location: Room 144
    Presenter: Emily Hubley, MS, DABR – University of Pennsylvania
  • 12:40 PM - 12:45 PM ET
    1144 - Development of Prediction Model for Right and Left Liver Hypertrophy to Estimate Response in Patients Treatments Simulated with Photon Based 3DCRT and IMRT Plans
    Location: Room 144
    Presenter: Aashish Gupta, MS – UT MD Anderson Cancer Center
  • 12:45 PM - 12:50 PM ET
    1145 - Institution Volumetric Modulated Arc Therapy Total Body Irradiation Technique Using Autoplanning Scripts: 4 Year Experience
    Location: Room 144
    Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
  • 12:50 PM - 12:55 PM ET
    1146 - Deep Learning-Based Dose Prediction for Thoracic Radiation in a Statewide Radiation Oncology Quality Consortium
    Location: Room 144
    Presenter: Daniel Polan, PhD – University of Michigan
  • 12:55 PM - 1:00 PM ET
    1147 - Clinical Implementation of an Automated VMAT Treatment Planning Script for Head and Neck Cancer Patients: 3 Year-Experience
    Location: Room 144
    Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
  • 1:00 PM - 1:05 PM ET
    1148 - General and Organ Specific Consensus Recommendations for Stereotactic Body Radiotherapy Dose Prescription according to ICRU Report 91 from Working Groups on Stereotactic Radiotherapy
    Location: Room 144
    Presenter: Thomas Brunner, MD – Medical University Graz
  • 1:05 PM - 1:25 PM ET
    Questions and Answers
    Location: Room 144
  • 1:25 PM - 1:30 PM ET
    Closing
    Location: Room 144
  • 12:30 PM - 12:35 PM ET
    Introduction
    Location: Room 143
  • 12:35 PM - 12:40 PM ET
    1155 - Patient 2D Imaging and Enhancement with a Novel Dual-Layer Kv Imager
    Location: Room 143
    Presenter: Dianne Ferguson, PhD, DABR – Brigham and Women's Hospital/Dana Farber Cancer Institute
  • 12:40 PM - 12:45 PM ET
    1156 - Metal Identification and Artifact Reduction Using a Dual-Layer CBCT Imager Prototype
    Location: Room 143
    Presenter: Matthew Jacobson, PhD – DFCI
  • 12:45 PM - 12:50 PM ET
    1157 - A Pilot Trial Testing a Novel 2D Antiscatter Grid and Quantitative CBCT Pipeline: An Interim Quantitative Image Quality Analysis
    Location: Room 143
  • 12:50 PM - 12:55 PM ET
    1158 - Optimizing Target and Diaphragmatic Configuration, and Dosimetric Benefits Using Continuous Positive Airway Pressure (CPAP) in Stereotactic Ablative Radiotherapy for Lung Tumors
    Location: Room 143
    Presenter: Jung Bin Park, MD – Seoul National University College of Medicine
  • 12:55 PM - 1:00 PM ET
    1159 - Addressing the Impact of Skin Pigmentation on Quantitative Cherenkov Dosimetry in the First Diverse Patient Imaging Study
    Location: Room 143
    Presenter: Savannah Decker, PhD, BS – UC San Diego Health
  • 1:00 PM - 1:05 PM ET
    1160 - Efficacy of Thermoplastic Mask Heating before Radiotherapy in Reducing Setup Error for Patients with Gynecological Tumor: A Randomized Controlled Study
    Location: Room 143
    Presenter: Rong Wang
  • 1:05 PM - 1:25 PM ET
    Questions and Answers
    Location: Room 143
  • 1:25 PM - 1:30 PM ET
    Closing
    Location: Room 143